2026 ICD-10-CM Diagnosis Code E07.89Other specified disorders of thyroid
ICD-10-CM Codes›E00–E89›E00-E07›E07
- Billable — Valid for Submission
- Not Chronic
E07.89 is a billable ICD-10-CM diagnosis code for other specified disorders of thyroid. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 11 through 13, 643 through 645. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Thyroid disorders.
E07.89 does not risk-adjust for Medicare Advantage under the CMS-HCC V28 model. It still risk-adjusts in the RxHCC Part D (V08) category 44 for payment year 2026.
Code Identity
Code Classification
Medicare Risk Adjustment (HCC)Billing
E07.89 does not risk-adjust for Medicare Advantage under the CMS-HCC V28 model, but it maps to payment categories in the other CMS models shown below.
Source: CMS Payment Year 2026 risk adjustment mappings and model software. Weights are relative factors, not dollar amounts; a beneficiary's total RAF also includes demographics and interactions. Browse all CMS-HCC categories.
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Ascher's syndrome
- Autosomal dominant excess of transthyretin
- Complex thyroid endocrine disorder
- Congenital double lip
- Congenital hypothyroidism due to peripheral resistance to thyroid hormone
- Congenital malposition of eyelid
- Drug interference with thyroid-binding globulin
- Dysprealbuminemic euthyroidal hyperthyroxinemia
- Euthyroid hyperthyroxinemia
- Euthyroid hypothyroxinemia
- Eyelid malposition
- Finding of appearance of thyroid gland
- Finding of size of thyroid gland
- Follicular lesion of thyroid
- Gangrene of thyroid
- Generalized thyroid hormone resistance
- Hematoma of neck
- Hemorrhage of thyroid
- Hemorrhagic infarction
- Hemorrhagic infarction of thyroid
- Hurthle cell metaplasia of thyroid gland
- Infarction of thyroid
- Intrathyroidal calcification AND goiter syndrome
- Neck swelling
- Peripheral resistance to thyroid hormone
- Pituitary thyroid hormone resistance
- Resistance to thyroid hormone due to mutation in thyroid hormone receptor beta
- Resistance to thyroid hormone syndrome
- Resistance to thyroid stimulating hormone syndrome
- Small thyroid gland
- Swelling of bilateral lobes of thyroid gland
- Thyrocerebrorenal syndrome
- Thyroglobulin proteolysis defect
- Thyroid degeneration
- Thyroid gland hematoma
- Thyroid hormone binding abnormality
- Thyroid hormone responsiveness defect
- Thyroid pre-albumin binding abnormality
- Thyroid stimulating hormone level above reference range
- Thyroid-binding globulin abnormality
- Thyroid-binding globulin deficiency
- Thyroid-binding globulin high
- Thyroxine plasma membrane transport defect
- Thyroxine transport defect
- Transient decreased production of thyroid hormone
- X-linked absence of thyroxine-binding globulin
- X-linked excess of thyroxine-binding globulin
- X-linked reduction of thyroxine-binding globulin
- X-linked variant form of thyroxine-binding globulin
Tabular List NotesGuidance
Coding notes and annotation back-references applicable to this code.
Inclusion Terms
- Abnormality of thyroid-binding globulin
- Hemorrhage of thyroid
- Infarction of thyroid
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
Abnormal, abnormality, abnormalities See Also: Anomaly;
thyroid-binding E07.89
thyroid-binding globulin E07.89
Disease, diseased See Also: Syndrome;
specified NEC E07.89
Disorder (of) See Also: Disease;
specified NEC E07.89
thyroid E07.89
Gangrene, gangrenous (connective tissue) (dropsical) (dry) (moist) (skin) (ulcer) See Also: Necrosis; I96
thyroid (gland) E07.89
Thyroid (gland) (body) See Also: condition;
hormone resistance E07.89
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Clinical InformationClinical
Hurthle Cell Metaplasia of Thyroid Gland
a morphologic finding indicating transformation of follicular cells to large cells with abundant eosinophilic and granular cytoplasm (hurthle cells) in the thyroid gland.
Patient EducationClinical
Thyroid Diseases
Your thyroid is a small, butterfly-shaped gland in the front of your neck. It makes hormones that control the way the body uses energy. These hormones affect nearly every organ in your body and control many of your body's most important functions. For example, they affect your breathing, heart rate, weight, digestion, and moods.
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert E07.89 to ICD-9-CMHistory
Code HistoryHistory
Questions About E07.89Overview
What is the ICD-10 code for other specified disorders of thyroid?
The ICD-10-CM code for other specified disorders of thyroid is E07.89 (sometimes written as E0789). It is billable on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
Is E07.89 (Other specified disorders of thyroid) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report other specified disorders of thyroid on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What MS-DRG does E07.89 group to?
When other specified disorders of thyroid is the principal diagnosis on an inpatient stay, it groups to MS-DRG 11, 12, 13, 643, 644, 645, with relative weights from 0.7683 to 5.4541 depending on complications. Higher weights mean higher Medicare reimbursement.
What is the ICD-9 equivalent of E07.89?
Under the General Equivalence Mappings, other specified disorders of thyroid converts to ICD-9-CM 246.3 (hemorr/infarc thyroid) and 246.8 (disorders of thyroid NEC). The mapping is approximate, so confirm the match fits the documentation.
Does E07.89 risk-adjust for Medicare Advantage payment?
Not for Medicare Advantage: E07.89 maps to no category in the CMS-HCC V28 model. It still risk-adjusts in the RxHCC Part D (V08) category 44 (Thyroid Disorders).